ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Clinical trials for ADAMANTINOMATOUS CRANIOPHARYNGIOMA explained in plain language.
Never miss a new study
Get alerted when new ADAMANTINOMATOUS CRANIOPHARYNGIOMA trials appear
Sign up with your email to follow new studies for ADAMANTINOMATOUS CRANIOPHARYNGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Arthritis drug shows promise against rare childhood brain tumor
Disease control Recruiting nowThis study tests a drug called tocilizumab, already used for arthritis, in children and young adults with a rare brain tumor called adamantinomatous craniopharyngioma that has come back or is growing. The goal is to see if the drug can shrink the tumor or stop it from growing. Ab…
Matched conditions: ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
New hope for Hard-to-Treat cancers: FOG-001 trial launches
Disease control Recruiting nowThis study tests a new drug, FOG-001, in about 595 people whose solid tumors (like colorectal, prostate, or endometrial cancer) have spread or can't be removed by surgery. The main goals are to see if the drug is safe and if it can shrink tumors or slow their growth. Participants…
Matched conditions: ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC